130 related articles for article (PubMed ID: 34007331)
1. Prognostic value of MTA1, SOX4 and EZH2 expression in esophageal squamous cell carcinoma.
Liu W; Xia Y; Li M; Abulajiang G; Wang H; Su L; Li C; Shi Y; Zhang W; Xu S; Ma Y
Exp Ther Med; 2021 Jul; 22(1):722. PubMed ID: 34007331
[TBL] [Abstract][Full Text] [Related]
2. TGF-β-MTA1-SMAD7-SMAD3-SOX4-EZH2 Signaling Axis Promotes Viability, Migration, Invasion and EMT of Hepatocellular Carcinoma Cells.
Zhang K; Fang T; Shao Y; Wu Y
Cancer Manag Res; 2021; 13():7087-7099. PubMed ID: 34531686
[TBL] [Abstract][Full Text] [Related]
3. A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis.
Li L; Liu J; Xue H; Li C; Liu Q; Zhou Y; Wang T; Wang H; Qian H; Wen T
Oncogene; 2020 Mar; 39(10):2125-2139. PubMed ID: 31811272
[TBL] [Abstract][Full Text] [Related]
4. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
[TBL] [Abstract][Full Text] [Related]
5. Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients.
Liu F; Gu L; Cao Y; Fan X; Zhang F; Sang M
Biomarkers; 2016; 21(1):80-90. PubMed ID: 26631178
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of vasculogenic mimicry, vascular endothelial cadherin and SOX4 in patients with esophageal squamous cell carcinoma.
Qin Y; Zhao W; Cheng L; Wu S; Wu Q; Gao J; Bian Z; Ma L
Int J Clin Exp Pathol; 2019; 12(7):2462-2473. PubMed ID: 31934073
[TBL] [Abstract][Full Text] [Related]
7. [Expression of enhancer of zeste homolog 2 in esophageal squamous cell carcinoma and its prognostic value in postoperative patients].
Wang HR; Wang MH; Lian GY; Wu DG
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):99-102. PubMed ID: 25613619
[TBL] [Abstract][Full Text] [Related]
8. [Expression of enhancer of zeste homolog 2 in esophageal squamous cell carcinoma and its prognostic value in postoperative patients].
Wang H; Wang M; Lian G; Wu D
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):99-102. PubMed ID: 23353165
[TBL] [Abstract][Full Text] [Related]
9. Correlation between insulin‑like growth factor binding protein 3 and metastasis‑associated gene 1 protein in esophageal squamous cell carcinoma.
Yang H; Xu L; Qian H; Niu X; Zhao D; Zhao Z; Wu J; Liu J; Wang Y
Mol Med Rep; 2016 May; 13(5):4143-50. PubMed ID: 27035126
[TBL] [Abstract][Full Text] [Related]
10. Associations between the expression of MTA1 and VEGF-C in esophageal squamous cell carcinoma with lymph angiogenesis and lymph node metastasis.
Liu J; Xia J; Zhang Y; Fu M; Gong S; Guo Y
Oncol Lett; 2017 Sep; 14(3):3275-3281. PubMed ID: 28927077
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA.
Qiu BQ; Lin XH; Ye XD; Huang W; Pei X; Xiong D; Long X; Zhu SQ; Lu F; Lin K; Zhang XQ; Xu JJ; Sheng LL; Zhang XM; Zhang PF; Wu YB
Aging (Albany NY); 2020 Jan; 12(2):1843-1856. PubMed ID: 32005028
[TBL] [Abstract][Full Text] [Related]
12. High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
He LR; Liu MZ; Li BK; Jia WH; Zhang Y; Liao YJ; Chen YC; Zhang LJ; Guan XY; Zeng YX; Kung HF; Xie D
Int J Cancer; 2010 Jul; 127(1):138-47. PubMed ID: 19904743
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the correlativity of gender determining region Y-box 4, N-cadherin, CD44 and E-cadherin expression in the prognosis of esophageal squamous cell carcinoma.
Qin Y; Zhao W; Cheng L; Gao J; Bian Z; Wu S; Cheng Z; Tao Y; Ma L
Int J Clin Exp Pathol; 2019; 12(5):1745-1756. PubMed ID: 31933993
[TBL] [Abstract][Full Text] [Related]
15. MTA1: a prognosis indicator of postoperative patients with esophageal carcinoma.
Song L; Wang Z; Liu X
Thorac Cardiovasc Surg; 2013 Sep; 61(6):479-85. PubMed ID: 22547301
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2.
Wang W; Zhu Y; Li S; Chen X; Jiang G; Shen Z; Qiao Y; Wang L; Zheng P; Zhang Y
Oncotarget; 2016 May; 7(18):25668-82. PubMed ID: 27015363
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus.
Yamada A; Fujii S; Daiko H; Nishimura M; Chiba T; Ochiai A
Int J Oncol; 2011 Feb; 38(2):345-53. PubMed ID: 21165554
[TBL] [Abstract][Full Text] [Related]
18. Metastasis-associated protein 1 promotes tumor invasion by downregulation of E-cadherin.
Weng W; Yin J; Zhang Y; Qiu J; Wang X
Int J Oncol; 2014 Mar; 44(3):812-8. PubMed ID: 24424621
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA linc-UBC1 promotes tumor invasion and metastasis by regulating EZH2 and repressing E-cadherin in esophageal squamous cell carcinoma.
Niu G; Zhuang H; Li B; Cao G
J BUON; 2018; 23(1):157-162. PubMed ID: 29552776
[TBL] [Abstract][Full Text] [Related]
20. A crucial epithelial to mesenchymal transition regulator, Sox4/Ezh2 axis is closely related to the clinical outcome in pancreatic cancer patients.
Hasegawa S; Nagano H; Konno M; Eguchi H; Tomokuni A; Tomimaru Y; Asaoka T; Wada H; Hama N; Kawamoto K; Marubashi S; Nishida N; Koseki J; Mori M; Doki Y; Ishii H
Int J Oncol; 2016 Jan; 48(1):145-52. PubMed ID: 26648239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
